Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,071 $ 21,092
Short-term investments 17,859 39,712
Prepaid expenses and other current assets 1,628 1,338
Income taxes receivable 38 302
Total current assets 25,596 62,444
Intangible asset, net   1,719
Property and equipment, net 51 69
Restricted cash 34 34
Other assets 578 2,567
Total assets 26,259 66,833
Current liabilities:    
Accounts payable 4,996 2,774
Accrued expenses 7,761 4,346
Derivative liability   196
Other current liabilities 761 1,748
Total current liabilities 13,518 9,064
Long-term debt 11,453 10,094
Royalty-linked notes 7,503 18,372
Other liabilities 188 1,304
Total liabilities 32,662 38,834
Commitments and contingencies (Note 15)
Shareholders' (deficit) / equity    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at December 31, 2023 and December 31,2022; no shares issued at December 31, 2023 and December 31, 2022
Ordinary shares, $0.01 par value per share: 80,000,000 shares authorized at December 31, 2022, 13,499,003 shares issued at December 31, 2023; 12,598,641 shares issued at December 31, 2022 135 126
Additional paid-in capital 454,759 451,150
Accumulated deficit (461,298) (422,927)
Accumulated other comprehensive gain / (loss) 1 (350)
Total shareholders' (deficit) / equity (6,403) 27,999
Total liabilities and shareholders' (deficit) / equity $ 26,259 $ 66,833